Advertisement Cyanotech expands production capacity of Astaxanthin - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cyanotech expands production capacity of Astaxanthin

Cyanotech, a provider of microalgae technology, has increased the production capacity of Astaxanthin by 33% at its facility in Kona, Hawaii.

Astaxanthin is a natural supplement which has antioxidant activity, supports anti-inflammatory response besides improving skin, muscle and joint health.

Cyanotech president and CEO Brent Bailey said the company has increased the production following a rise in demand.

"We want to be sure we have capacity to fill the needs of all our customers in a timely manner, and be sure that all the consumers who want to try this exceptional nutrient can get it," Bailey added.